ASCO20: a nanomedicine news round up

Written by Lucy Chard, Editor

ASCO20 clinical medicine

The American Society of Clinical Oncology 2020 (ASCO20) Virtual Annual Meeting highlights discoveries in medicine to ensure clinical research in oncology remains at the cutting edge. Nanotechnology has been highlighted this year in work showcasing the future of nano-oncological research. Pre-clinical Much nanomedical research for cancer therapeutics is still in the early pre-clinical stages. A main focus of this research is in the improvement of drug delivery, in which nanotechnology can be used to combine different therapeutic tactics on the nanoscale to bring about safer and more effective delivery methods. At ASCO20 some of these innovative techniques were presented.  ...

To view this content, please register now for access

It's completely free